MPS provides digital content engineering, platform technology, and e-learning solutions to academic publishers, educational institutions, and corporate clients globally. It earns revenue through service contracts, software-as-a-service subscriptions, and medical knowledge management platforms.
The company possesses a narrow moat driven by high switching costs and deep workflow integration. Its platforms like HighWire and Unbound Medicine are embedded in the daily operations of hospitals and publishers, evidenced by a 97% retention rate and stable EBITDA margins exceeding 30%.
Management follows a disciplined 'earn or return' policy, having returned over 650 crore INR to shareholders since 2019. Recent capital has been pivoted toward high-margin growth acquisitions like Unbound Medicine and AJE, which are rapidly integrated to meet internal return thresholds.
The downfall began when the aggressive acquisition strategy finally hit a wall of indigestion. Management overpaid for a large target to sustain growth, but the integration failed to replicate the success of Unbound Medicine, leading to a massive goodwill impairment. Simultaneously, the heavy customer concentration in the Research segment proved fatal as a major client insourced their workflow or shifted to an AI-native competitor, causing the high-margin revenue base to evaporate. The 'earn or return' policy was abandoned to service new debt, and the once-clean balance sheet became a burden as organic growth stalled in a commoditizing market.
RichFakir rates MPS Ltd's business quality as wonderful — 86/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, MPS Ltd is trading about 8% below our estimate of fair value; we rate its price fair. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on MPS Ltd is: Buy candidate. A wonderful business trading below what we think it is worth — so it makes our buy list.
RichFakir's educational estimate of MPS Ltd's fair value is about ₹2,527 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →